On the other hand—when compared to the other two genotypes (i.e., N/N, N/D)—the homozygous GSTO2*N142D (D/D) genotype was found to be associated with a lower risk of gastric cancer in subjects without a history of cancer in their first-degree relatives. This evidence concerns the gene GSTO2 and gastric cancer.